CAR-T Therapy work flow

There are several steps in the manufacture of genetically recombined CAR-T cells and injection into cancer patients.  

​

1. T cells are extracted from the patient's blood through Leukapheresis. ​

​

2. Using a viral vector, DNA designed as a cancer cell-specific chimeric antigen receptor (CAR) is injected into T cells (CAR transduction) and the cells are expanded (Expansion) ​

 

3. Finally, CAR-T cells are injected back into the patient.